PRAMEF2: A Potential Drug Target and Biomarker for the PRAME Family

Target Name: PRAMEF2

NCBI ID: G65122

Other Name(s): PRAME family member 2 | RP5-845O24.1 | DJ845O24.3 | PRAM2_HUMAN

PRAMEF2: A Potential Drug Target and Biomarker for the PRAME Family

The PRAME family is a family of proteins that play a crucial role in the regulation of cell growth, differentiation, and inflammation. PRAMEF2, a member of the PRAME family, has been identified as a potential drug target and biomarker. In this article, we will discuss the biology of PRAMEF2, its potential as a drug target, and its potential as a biomarker for various diseases.

The PRAME family consists of four proteins: PRAME1, PRAME2, PRAME3, and PRAME4. These proteins share a conserved catalytic core and a common framework that includes a heptadecapeptide loop and a carboxylic acid residue. PRAME2 is a 21-kDa protein that is expressed in various tissues, including brain, heart, skeletal muscles, and testes. It is highly conserved and has been shown to play a role in the development and maintenance of tissues, including the nervous system and immune system.

PRAMEF2 is a 12-kDa protein that is highly conserved with PRAME1, PRAME3, and PRAME4. It is expressed in various tissues, including the brain, spleen, and heart. PRAMEF2 has been shown to play a role in the regulation of cell adhesion, migration, and invasion. It is also involved in the regulation of inflammation and has been shown to play a role in the development of cancer.

As a potential drug target, PRAMEF2 has been identified for its role in the regulation of cell adhesion and its potential as a therapeutic target for various diseases. The regulation of cell adhesion is critical for the development and maintenance of tissues and is involved in many important biological processes, including embryonic development, tissue repair, and cancer progression.

PRAMEF2 has been shown to play a role in the regulation of cell adhesion by interacting with several different proteins, including cadherins, integrins, and vimentin. It is also involved in the regulation of cell migration and invasion, which are critical processes for the development and progression of tissues. PRAMEF2 has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

As a potential biomarker, PRAMEF2 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is a potential target for small molecule inhibitors and has been shown to be involved in the regulation of cellular signaling pathways that are involved in disease progression.

In conclusion, PRAMEF2 is a highly conserved protein that plays a critical role in the regulation of cell growth, differentiation, and inflammation. As a potential drug target and biomarker, PRAMEF2 is a promising target for the development of new therapies for various diseases. Further research is needed to fully understand the biology of PRAMEF2 and its potential as a therapeutic target.

Protein Name: PRAME Family Member 2

More Common Targets